New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?: Table 1.

AspergillusPolymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing

(2015) P. Lewis White et al.   CLINICAL INFECTIOUS DISEASES

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus

(2015) Paul E. Verweij et al.   DRUG RESISTANCE UPDATES

High prevalence of azole resistance inAspergillus fumigatusisolates from high-risk patients

(2015) J. Fuhren et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany

(2015) J. Steinmann et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Validation of a New Aspergillus Real-Time PCR Assay for Direct Detection of Aspergillus and Azole Resistance of Aspergillus fumigatus on Bronchoalveolar Lavage Fluid

(2015) Ga-Lai M. Chong et al.   JOURNAL OF CLINICAL MICROBIOLOGY

High diversity of non-sporulating moulds in respiratory specimens of immunocompromised patients: should all the species be reported when diagnosing invasive aspergillosis?

(2015) Dea Garcia-Hermoso et al.   MYCOSES

Diagnosis and management of aspergillosis in the Netherlands: a national survey

(2015) Pieter P. A. Lestrade et al.   MYCOSES

What is the importance of classifyingAspergillusdisease in cystic fibrosis patients?

(2014) Andrew M Jones et al.   Expert Review of Respiratory Medicine

ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia

(2012) M C Arendrup et al.   BONE MARROW TRANSPLANTATION

High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis

(2012) F. Morio et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus

(2012) Eveline Snelders et al.   PLoS One

High Prevalence of Azole-Resistant Aspergillus fumigatus in Adults with Cystic Fibrosis Exposed to Itraconazole

(2011) Pierre-Régis Burgel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients

(2011) O Marchetti et al.   BONE MARROW TRANSPLANTATION

High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease

(2011) David W. Denning et al.   CLINICAL INFECTIOUS DISEASES

Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)

(2011) O. Lortholary et al.   CLINICAL MICROBIOLOGY AND INFECTION

Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies

(2010) A. Alanio et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

(2008) Brahm H. Segal et al.   CLINICAL INFECTIOUS DISEASES